Delivery Order SPE2DB22D1017-SPE2DB25FYPHW
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for WIXELA 250-50 inhalation powder (60-unit package) with a ceiling value of $1,733.01. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,483.86 to AmerisourceBergen Drug Corp for WIXELA 100-50 inhalation powder, a combination asthma and COPD medication. Issued on August 5, 2025, with an ultimate completion date of August 6, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $1,148.66 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. WIXELA is a combination inhaled medication used in respiratory disease treatment, representing a...
- The Defense Logistics Agency awarded a $2,141.04 delivery order to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price contract, which is a child order under a larger contract vehicle, involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. WIXELA is a combination inhalation medication used in respiratory therapy, reflecting...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,231.35 for WIXELA 250-50 INHUB 60S, a pharmaceutical product, with a completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child task order under AmerisourceBergen Drug Corp's larger contract vehicle with the...
- The Defense Logistics Agency awarded a $1,290.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for WIXELA 250-50 INHUB 60S, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by August 12, 2025. This is a non-set-aside, competitively awarded contract issued as a child delivery order under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,349.80 to AmerisourceBergen Drug Corp for WIXELA 500-50 INHUB 60S, a pharmaceutical product, with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,098.93 by the Defense Logistics Agency on August 20, 2025, for the supply of Wixela 250-50 inhalation powder in 60-count packages. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open procurement. The place of performance is located in Conshohocken,...
- This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,080.48, is for the delivery of WIXELA 500-50 INHUB 60S pharmaceutical products. The contract has an ultimate completion date of July 2, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Wixela 500-50 inhub 60s, a pharmaceutical product, on August 5, 2025, with a ceiling value of $3,241.44. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, represents performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The contract is a child order issued under AmerisourceBergen's larger...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPHWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,022.88 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalation powder (60 doses), a combination pharmaceutical product, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed on August 27, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply an extensive range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. The contract vehicle serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/27/25 |